Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

477 public trials 97 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Active, Not Recruiting

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

NCT02926911

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +9 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 141 locations
View Trial Details
Active, Not Recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046

Conditions
Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

NCT03157128

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 85 locations
View Trial Details

Related conditions